Internal Medicine, Hematology & Oncology · Nashville, TN
NPI
1871634204
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
3601 the Vanderbilt Clinic
Nashville, TN, 37232
Phone (615) 936-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
455 services
Medicare patients, 2024
166
Average age 71
Drug cost, 2024
$659K
331 prescriptions
Company payments, 2025
$12K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vicki Keedy was code 99215 (office e&m - established), 170 times for 57 patients. In total Vicki Keedy billed 455 services in 15 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 170 | 57 | $103.82 | $18K |
| 99214 Office E&M - Established | Facility | 97 | 57 | $64.12 | $6,220 |
| 99232 Hospital E&M - Subsequent | Facility | 52 | 23 | $61.06 | $3,175 |
| 99205 Office E&M - New | Facility | 32 | 32 | $133.04 | $4,257 |
| 99213 Office E&M - Established | Facility | 27 | 25 | $45.72 | $1,234 |
| 99222 Hospital E&M - Initial | Facility | 19 | 18 | $90.16 | $1,713 |
| 99238 Hospital Discharge Management | Facility | 16 | 16 | $58.86 | $942 |
By year: 2022 $34K for 404 services; 2023 $39K for 452 services; 2024 $40K for 455 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vicki Keedy prescribed most often to Medicare patients was Imatinib Mesylate, with 70 prescriptions and refills. In total Vicki Keedy wrote 331 Medicare prescriptions that cost $659K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 70 | 70 | Under 11 | $65K |
| Votrient Pazopanib Hcl | 31 | 31 | Under 11 | $320K |
| Dexamethasone Generic | 27 | 29 | Under 11 | $203 |
| Ondansetron Hcl Generic | 20 | 20 | 12 | $168 |
| Pazopanib Hcl Generic | 18 | 18 | Under 11 | $107K |
| Prochlorperazine Maleate Generic | 17 | 17 | Under 11 | $176 |
Brand drugs: 55 claims; generic drugs: 276 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vicki Keedy $12K ($12K in general payments such as food, travel and fees) from 4 companies. The largest payer was Deciphera Pharmaceuticals Inc. with $8,048.
| Company | Payments | Amount |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 7 | $8,048 |
| EMD Serono Research & Development Institute, Inc. MRK.DE | 1 | $4,216 |
| Aadi Bioscience, Inc. | 1 | $127 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.